SEC Form 3 · accession 0000899243-18-008121

Corindus Vascular Robotics, Inc. · CVRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

10% Owner

10% Owner

Period of report

Mar 16, 2018

Accepted (ET)

Mar 20, 2018 · 4:46 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001528557

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2,F3	holding	—	—		—	11,336,154	I	See footnotes

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A Preferred Stock^F1,F2,F3,F4	$1.25	holding	—	—	—	Mar 16, 2018	—	Common Stock	10,800,000	—	I
Warrant^F1,F2,F3	$1.40	holding	—	—	—	Sep 16, 2018	Mar 16, 2028	Common Stock	4,725,000	—	I

F1In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 3 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP" and, together with Hudson Executive, the "Reporting Persons"), which has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially reported on this Form 3 (the "Subject Securities").
F2Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a 1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a).
F3Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.
F4The preferred stock is perpetual and therefore has no expiration date.